Product image

Genesis MR Tablets

Genesis MR – Modified-Release Diabetes Management

Genesis MR is an anti-diabetic medication containing Gliclazide in a modified-release format, designed for the effective management of metabolic health. It is specifically indicated for the treatment of type 2 diabetes mellitus in adult patients when diet and exercise alone are insufficient for blood sugar control. As a second-generation sulfonylurea, it stimulates the pancreas to secrete more insulin, helping to lower elevated glucose levels. The "MR" or modified-release technology allows the active ingredient to be released gradually over a 24-hour period. This provides steady and reliable glycemic control throughout the day and night with just a single daily dose. Genesis MR is effective at lowering HbA1c levels, which is a critical marker for preventing the long-term vascular complications of diabetes. It is typically taken with breakfast to ensure optimal protection during the day's meals. Regular blood sugar monitoring is recommended to ensure the treatment is tailored to the patient's individual metabolic needs.

  • Indicated for the treatment of type 2 diabetes mellitus.
  • Modified-release formula for steady 24-hour glucose control.
  • Stimulates natural insulin production in response to meals.
  • Available as: Tablets 30mg and 60mg.

You may also like

Take it to your cart

Ezole Capsules
Ezole Capsules

Ezole Capsules – Targeted Suppression of Stomach Acid

Ezole Capsules contain Esomeprazole, a potent proton pump inhibitor de...

Risek Capsules
Risek Capsules

Risek Capsules – Comprehensive Acid-Related Disease Management

Risek is a established gastrointestinal treatment used for a...

EN-URA Tablets
EN-URA Tablets

EN-URA Tablets – Targeted Relief for Overactive Bladder

EN-URA is a specialized therapeutic option designed to manage bother...

Saltra Inhaler
Saltra Inhaler

Saltra Inhaler – Comprehensive Respiratory Maintenance Therapy

Saltra Inhaler is a specialized respiratory medication used f...

Image NewsLetter
Icon primary
Newsletter

Subscribe our newsletter

By clicking the button, you are agreeing with our Term & Conditions

Your experience on this site will be improved by allowing cookies Cookie Policy